搜索临床试验以:普拉甾酮 6.5 毫克(0.50%)阴道插入物
总计366个结果
-
Boehringer Ingelheim完全的
-
Novartis Pharmaceuticals完全的增生性糖尿病视网膜病变 (PDR)德国
-
Merck Sharp & Dohme LLC完全的
-
King's College Hospital NHS TrustKing's College London主动,不招人
-
Fundación Universitaria de Ciencias de la SaludHospital de San Jose终止
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Boston Children's HospitalBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Stanford University; Thomas...招聘中
-
Wake Forest University Health Sciences主动,不招人
-
Hamilton Health Sciences CorporationCanadian Institutes of Health Research (CIHR); Population Health Research Institute招聘中
-
Hospital Universitari de BellvitgeInstitut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos III招聘中
-
Rare Partners srl Impresa SocialeUniversità degli Studi di Ferrara完全的
-
Università degli Studi di FerraraAzienda Ospedaliero, Universitaria Pisana; Rare Partners srl Impresa Sociale; Azienda Ospedaliero...招聘中
-
University of ManitobaHealth Sciences Centre Foundation, Manitoba; Canadian Paraplegic Association; The Manitoba Spinal...完全的
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development招聘中
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São Paulo未知
-
Novartis Pharmaceuticals完全的继发于病理性近视 (PM) 的脉络膜新生血管 (CNV) 导致的视力障碍中国, 印度, 泰国, 香港, 大韩民国, 菲律宾
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)招聘中
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National... 和其他合作者完全的